Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the effects of the UK's departure from the EU on the National Health Service.

As part of our reforms following the United Kingdom’s departure from the European Union (EU), provisions within the Medicines and Medical Devices Act 2021 enable us to overhaul medical devices and clinical trial frameworks so patients can get access to new lifesaving medicines and medical devices more quickly. The Department closely monitors National Health Service and adult social care staffing levels in England, with data showing that since leaving the EU we have seen an increase in EU/EEA staff working in the NHS.

We are also working closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved governments, and other stakeholders to ensure patients continue to have access to the treatments they need.